The U.S. Food and Drug Administration today announced its Commissioner’s National Priority Voucher (CNPV) program to enhance the health interests of Americans. The new voucher may be redeemed by drug developers to participate in a novel priority program by the FDA that shortens its review time from approximately 10-12 months to 1-2 months following a sponsor’s final drug application submission.Continue reading
Category Archives: AZBio News
Global Impact of Phoenix Bioscience Core and TGen Featured in New BBC Content Series
BOSTON – The Translational Genomics Research Institute (TGen), part of City of Hope, took part in a new global content series presented by the Biotechnology Innovation Organization (BIO) and produced by BBC StoryWorks Commercial Productions. TGen is a leading biomedical research organization based in the Phoenix Bioscience Core (PBC).
Smart sensors and smarter health: How AI and wearables are reimagining preventive health care
University of Arizona Health Sciences researchers are harnessing artificial intelligence and wearable tech to forecast labor, detect stress and transform how we monitor our health – before symptoms appear.Continue reading
BioLab Holdings Founders Honored as Entrepreneurs of the Year
Robert Maguire & Jaime Leija, Cofounders of BioLab Holdings, Inc. in Mesa, Arizona were honored with the EY Entrepreneur Of The Year 2025 Pacific Southwest Award
CND Life Sciences’ Syn-One Test® Detects Alpha-Synuclein in Skin Biopsies of Patients with REM Sleep Behavior Disorder
Data from the Syn-Sleep Study shows the Syn-One Test detected phosphorylated alpha-synuclein in skin biopsies of 75% of patients with iRBD at baseline
This NIH-sponsored, multicenter, prospective study is being conducted at 11 sites across the U.S. and involves 80 participants
Rick G. Schnellmann, a Transformational Dean with an Entrepreneurial Spirit, Steps Down After Nine Years
Dean Rick Schnellmann, PhD, shared with Provost Prelock and President Garimella his decision to step down, effective June 30, 2025. He will return to his tenured faculty position in the Department of Pharmacology and Toxicology after a one-year research leave before resuming research in July 2026.Continue reading
Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with Prestigious Lifetime Achievement Award by The American Business Awards®
Gold-level Stevie® Award recognizes Maetzold’s transformative leadership in the healthcare industry, including molecular diagnostics and precision medicine
“Derek’s vision and unwavering commitment to improving patient care have been the driving force behind Castle Biosciences’ remarkable success story,”Continue reading
Applications are open for the new IMPACT Masters Program at ASU
Imagine the IMPACT of a Biodesign program at the intersection of the #1 most innovative university (Arizona State University) and the #1 hospital in the world (Mayo Clinic)…Continue reading
ASU to help target how cancer evades treatment
Up to $142M in funding announced for research group that includes MIT and StanfordContinue reading